Yao-Tseng Chen Selected Research

Antigens

06/2008	ECSA/DPPA2 is an Embryo-Cancer Antigen that Is Coexpressed with Cancer-Testis Antigens in Non-Small Cell Lung Cancer.
11/2007	NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy.
08/2007	Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals.
02/2007	Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients.
01/2006	Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6).
01/2006	NY-ESO-1: review of an immunogenic tumor antigen.
08/2005	Cancer/testis antigens, gametogenesis and cancer.
07/2005	The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation.
05/2005	Identification of cancer/testis-antigen genes by massively parallel signature sequencing.
01/2005	Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes.
01/2005	Identification of CT46/HORMAD1, an immunogenic cancer/testis antigen encoding a putative meiosis-related protein.
12/2004	Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.
11/2004	Real-Time, label-free monitoring of tumor antigen and serum antibody interactions.
11/2004	Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer.
11/2004	Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer.
10/2003	Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen.
10/2003	SSX antigens as tumor vaccine targets in human sarcoma.
10/2003	Expression of cancer/testis (CT) antigens in lung cancer.
09/2003	NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
07/2003	Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.
10/2002	Cancer/testis antigens: an expanding family of targets for cancer immunotherapy.
08/2002	Urine antibody against human cancer antigen NY-ESO-1.
06/2002	Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.

Articles by Research Topic

Disease

15	Testicular Neoplasms (Testicular Cancer) 06/2008 - 04/2002
13	Neoplasms (Cancer) 06/2008 - 06/2002
3	Carcinoma (Carcinomatosis) 11/2007 - 06/2005
2	Thyroid Neoplasms (Thyroid Cancer) 09/2008 - 11/2006
2	Prostatic Neoplasms (Prostate Cancer) 09/2007 - 07/2003
2	Melanoma (Melanoma, Malignant) 02/2007 - 12/2004
2	Renal Cell Carcinoma (Grawitz Tumor) 12/2006 - 09/2005
2	Oxyphilic Adenoma (Oncocytoma) 12/2006 - 09/2005
2	Breast Neoplasms (Breast Cancer) 01/2005 - 06/2002
2	Lung Neoplasms (Lung Cancer) 11/2004 - 10/2003
1	Small Cell Carcinoma 06/2008
1	Multiple Myeloma 07/2005
1	Stomach Neoplasms (Stomach Cancer) 11/2004
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2003
1	Neuroblastoma 10/2003
1	Sarcoma (Soft Tissue Sarcoma) 10/2003
1	Ovarian Neoplasms (Ovarian Cancer) 09/2003

Drug/Important Bio-Agent (IBA)

23	AntigensIBA 06/2008 - 06/2002
4	Messenger RNA (mRNA)IBA 09/2005 - 04/2002
2	HLA-A2 Antigen (HLA A2 Antigen)IBA 01/2005 - 09/2002
1	MicroRNAs (MicroRNA)IBA 09/2008
1	ParaffinIBA 09/2007
1	Proteins (Proteins, Gene)IBA 12/2006
1	Galectin 3 (LGALS3)IBA 11/2006
1	AntibodiesIBA 06/2005
1	EpitopesIBA 01/2005
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 12/2003
1	SCP 1IBA 06/2002

Therapy/Procedure

3	Immunotherapy 11/2007 - 10/2002